4.1 Article

Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47)

期刊

NEUROGENETICS
卷 13, 期 1, 页码 73-76

出版社

SPRINGER
DOI: 10.1007/s10048-012-0314-0

关键词

SPG47; AP4; AP4B1; Spastic paraplegia; Complicated

资金

  1. Deutsche Forschungsgemeinschaft [SCHO 754/5-1]
  2. e-rare program [01GM0807]
  3. EC [TECHGENE, FP7-Health 2007-B223143]

向作者/读者索取更多资源

We recently identified a new locus for spastic paraplegia type 47 (SPG47) in a consanguineous Arabic family with two affected siblings with progressive spastic paraparesis, intellectual disability, seizures, periventricular white matter changes and thin corpus callosum. Using exome sequencing, we now identified a novel AP4B1 frameshift mutation (c.664delC) in this family. This mutation was homozygous in both affected siblings and heterozygous in both parents. The mutant allele was absent in 316 Caucasian and 200 ethnically matched control chromosomes. We propose that AP4B1 mutations cause SPG47 and should be considered in early onset spastic paraplegia with intellectual disability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Association of Age at Onset and First Symptoms With Disease Progression in Patients With Metachromatic Leukodystrophy

Christiane Kehrer, Saskia Elgun, Christa Raabe, Judith Bohringer, Stefanie Beck-Wodl, Andrea Bevot, Nadja Kaiser, Ludger Schols, Ingeborg Krageloh-Mann, Samuel Groeschel

Summary: This study compared disease progression in different onset forms of metachromatic leukodystrophy (MLD) and found that the type of first symptoms predicts the rate of disease progression, providing important insights for counseling and therapy.

NEUROLOGY (2021)

Article Clinical Neurology

Bi-allelic truncating mutations in VWA1 cause neuromyopathy

Marcus Deschauer, Holger Hengel, Katrin Rupprich, Martina Kreiss, Beate Schlotter-Weigel, Mona Grimmel, Jakob Admard, Ilka Schneider, Bader Alhaddad, Anastasia Gazou, Marc Sturm, Matthias Vorgerd, Ghassan Balousha, Osama Balousha, Mohammed Falna, Jan S. Kirschke, Cornelia Kornblum, Berit Jordan, Torsten Kraya, Tim M. Strom, Joachim Weis, Ludger Schoels, Ulrike Schara, Stephan Zierz, Olaf Riess, Thomas Meitinger, Tobias B. Haack

Summary: The VWA1 protein is a new disease gene associated with neuromuscular disorders, causing muscle weakness in patients with common early childhood foot deformities. The disease presents with neurogenic and myopathic pathology features.
Correction Genetics & Heredity

Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment (vol 22, pg 1851, 2020)

Thomas Roux, Mathieu Barbier, Melanie Papin, Claire-Sophie Davoine, Sabrina Sayah, Giulia Coarelli, Perrine Charles, Cecilia Marelli, Livia Parodi, Christine Tranchant, Cyril Goizet, Stephan Klebe, Ebba Lohmann, Lionel Van Maldergem, Christine van Broeckhoven, Marie Coutelier, Christelle Tesson, Giovanni Stevanin, Charles Duyckaerts, Alexis Brice, Alexandra Durr

Summary: A correction to this paper has been published.

GENETICS IN MEDICINE (2021)

Correction Biochemistry & Molecular Biology

First-line exome sequencing in Palestinian and Israeli Arabs with neurological disorders is efficient and facilitates disease gene discovery (vol 28, pg 1034, 2020)

Holger Hengel, Rebecca Buchert, Marc Sturm, Tobias B. Haack, Yvonne Schelling, Muhammad Mahajnah, Rajech Sharkia, Abdussalam Azem, Ghassan Balousha, Zaid Ghanem, Mohammed Falana, Osama Balousha, Suhail Ayesh, Reinhard Keimer, Werner Deigendesch, Jimmy Zaidan, Hiyam Marzouqa, Peter Bauer, Ludger Schols

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Editorial Material Biochemistry & Molecular Biology

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

Birte Zurek, Kornelia Ellwanger, Lisenka E. L. M. Vissers, Rebecca Schuele, Matthis Synofzik, Ana Topf, Richarda M. de Voer, Steven Laurie, Leslie Matalonga, Christian Gilissen, Stephan Ossowski, Peter A. C. 't Hoen, Antonio Vitobello, Julia M. Schulze-Hentrich, Olaf Riess, Han G. Brunner, Anthony J. Brookes, Ana Rath, Gisele Bonne, Gulcin Gumus, Alain Verloes, Nicoline Hoogerbrugge, Teresinha Evangelista, Tina Harmuth, Morris Swertz, Dylan Spalding, Alexander Hoischen, Sergi Beltran, Holm Graessner

Summary: Solve-RD is a groundbreaking EU project that brings together rare disease experts to actively share and analyze patient data, aiming to solve unsolved rare diseases through innovative clinical research methods. The project has already seen success in diagnosing cases through massive data re-analysis and novel -omics approaches.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Biochemistry & Molecular Biology

Solving patients with rare diseases through programmatic reanalysis of genome-phenome data

Leslie Matalonga, Carles Hernandez-Ferrer, Davide Piscia, Rebecca Schuele, Matthis Synofzik, Ana Topf, Lisenka E. L. M. Vissers, Richarda de Voer, Raul Tonda, Steven Laurie, Marcos Fernandez-Callejo, Daniel Pico, Carles Garcia-Linares, Anastasios Papakonstantinou, Alberto Corvo, Ricky Joshi, Hector Diez, Ivo Gut, Alexander Hoischen, Holm Graessner, Sergi Beltran

Summary: Reanalysis of inconclusive exome/genome sequencing data can increase the diagnosis yield of patients with rare diseases, but the cost and effort required for reanalysis hinder its routine implementation. The Solve-RD project aims to uncover the molecular causes of undiagnosed rare diseases, successfully solving a portion of cases through innovative approaches to reanalyzing genomic data.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Genetics & Heredity

Major brain malformations: corpus callosum dysgenesis, agenesis of septum pellucidum and polymicrogyria in patients with BCORL1-related disorders

Michal Gafner, Marina Michelson, Emanuela Argilli, Keren Yosovich, Elliott H. Sherr, Kendall C. Parks, Eleina M. England, Ronen Hady-Cohen, Zvi Leibovitz, Dorit Lev, Yael Michaeli-Yosef, Tally Lerman-Sagie, Lubov Blumkin

Summary: Through case reports from two unrelated families, it was revealed that BCORL1 gene mutations may lead to major brain developmental abnormalities including hypoplastic corpus callosum, septal agenesis, and unilateral perisylvian polymicrogyria. The mothers of these patients were carriers of the mutated gene, indicating a potential influence of BCORL1 on brain development.

JOURNAL OF HUMAN GENETICS (2022)

Article Clinical Neurology

Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease Severity

Holger Hengel, Peter Martus, Jennifer Faber, Hector Garcia-Moreno, Nita Solanky, Paola Giunti, Thomas Klockgether, Kathrin Reetz, Bart P. van de Warrenburg, Luis Pereira de Almeida, Magda M. Santana, Cristina Januario, Patrick Silva, Andreas Thieme, Jon Infante, Jeroen de Vries, Manuela Lima, Ana F. Ferreira, Khalaf Bushara, Heike Jacobi, Chiadi Onyike, Jeremy D. Schmahmann, Jeannette Huebener-Schmid, Matthis Synofzik, Ludger Schoels

Summary: The study found that patients with SCA3 had lower levels of physical activity and alcohol consumption compared to controls. Less physical activity and alcohol abstinence were associated with more severe disease, but did not affect disease progression rates or age of onset.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study

Tim W. Rattay, Maximilian Voelker, Maren Rautenberg, Christoph Kessler, Isabel Wurster, Natalie Winter, Tobias B. Haack, Tobias Lindig, Holger Hengel, Matthis Synofzik, Rebecca Schule, Peter Martus, Ludger Schoels

Summary: This study explores early changes in the most common subtype of hereditary spastic paraplegia, SPG4, and identifies subclinical markers of disease activity in the prodromal stage. The findings suggest that certain clinical signs, such as increased reflexes and muscle weakness, may be more frequent in individuals who carry the genetic mutation associated with SPG4.
Article Medicine, Research & Experimental

Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons

Stefan Hauser, Jacob Helm, Melanie Kraft, Milena Korneck, Jeannette Huebener-Schmid, Ludger Schoels

Summary: Spinocerebellar ataxia type 3 (SCA3) is caused by an expanded polyglutamine stretch in ataxin-3. Researchers have identified ASOs that can effectively suppress both mutant and wild-type ataxin-3 expression, as well as an ASO that selectively reduces levels of mutant ataxin-3 while sparing wild-type expression. This study demonstrates the feasibility and long-lasting effects of allele-specific lowering of poly(Q)-expanded ataxin-3 using selective ASOs in a human cell culture model genetically identical to SCA3 patients.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Clinical Neurology

The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors

Holger Hengel, Peter Martus, Jennifer Faber, Paola Giunit, Hector Garcia-Moreno, Nita Solanky, Thomas Klockgether, Kathrin Reetz, Bart P. van de Warrenburg, Magda M. Santana, Patrick Silva, Ines Cunha, Luis Pereira de Almeida, Dagmar Timmann, Jon Infante, Jeroen de Vries, Manuela Lima, Paula Pires, Khalaf Bushara, Heike Jacobi, Chiadi Onyike, Jeremy D. Schmahmann, Jeannette Hubener-Schmid, Matthis Synofzik, Ludger Schoels

Summary: This study reveals that non-motor symptoms such as sleep disturbance, restless legs syndrome, mild cognitive impairment, depression, bladder dysfunction, and pallhypesthesia are common among SCA3 patients and are significantly associated with disease severity and daily activities. Lifestyle factors like alcohol consumption, smoking, and physical activity may also be related to non-motor symptoms.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Progressive Spinal Cord Degeneration in Friedreich's Ataxia: Results from ENIGMA-Ataxia

Thiago J. R. Rezende, Isaac M. Adanyeguh, Filippo Arrigoni, Benjamin Bender, Fernando Cendes, Louise A. Corben, Andreas Deistung, Martin Delatycki, Imis Dogan, Gary F. Egan, Sophia L. Goericke, Nellie Georgiou-Karistianis, Pierre-Gilles Henry, Diane Hutter, Neda Jahanshad, James M. Joers, Christophe Lenglet, Tobias Lindig, Alberto R. M. Martinez, Andrea Martinuzzi, Gabriella Paparella, Denis Peruzzo, Kathrin Reetz, Sandro Romanzetti, Ludger Schoels, Joerg B. Schulz, Matthis Synofzik, Sophia I. Thomopoulos, Paul M. Thompson, Dagmar Timmann, Ian H. Harding, Marcondes C. Franca

Summary: This study characterized cervical spinal cord structural damage in a large multisite cohort of Friedreich's ataxia (FRDA) patients. The results showed that FRDA patients had significantly reduced cross-sectional area (CSA) and increased eccentricity in the cervical spinal cord compared to control subjects. The CSA had significant correlations with disease severity, while eccentricity did not. Subgroup analyses revealed abnormal CSA and eccentricity at all disease stages, with CSA appearing to decrease progressively and eccentricity remaining stable over time.

MOVEMENT DISORDERS (2023)

Correction Clinical Neurology

The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors (vol 270, pg 944, 2023)

Holger Hengel, Peter Martus, Jennifer Faber, Paola Giunti, Hector Garcia-Moreno, Nita Solanky, Thomas Klockgether, Kathrin Reetz, Bart P. van de Warrenburg, Magda M. Santana, Patrick Silva, Ines Cunha, Luis Pereira de Almeida, Dagmar Timmann, Jon Infante, Jeroen de Vries, Manuela Lima, Paula Pires, Khalaf Bushara, Heike Jacobi, Chiadi Onyike, Jeremy D. Schmahmann, Jeannette Huebener-Schmid, Matthis Synofzik, Ludger Schoels

JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L

Maresa Buchholz, Niklas Weber, Anika Raedke, Jennifer Faber, Tanja Schmitz-Huebsch, Heike Jacobi, Feng Xie, Thomas Klockgether, Bernhard Michalowsky

Summary: The study confirmed an acceptable, reliable, valid, and responsive EQ-5D-3L in SCA patients, measuring HRQoL adequately, besides well-established clinical instruments.

CEREBELLUM (2023)

Letter Clinical Neurology

Chromium and cobalt intoxication mimicking mitochondriopathy

Tim W. Rattay, Torsten Kluba, Ludger Schoels

Summary: A 53-year-old male with a history of various health issues was referred to a rare disease center for suspected mitochondrial cytopathy, but genetic testing did not confirm this. It was only after experiencing hip pain which traced back to a hip arthroplasty 12 years prior that the cause of his symptoms was discovered to be related to metal-on-metal wear from the defective implant. Following implant replacement, the patient's condition significantly improved.

NEUROLOGICAL RESEARCH AND PRACTICE (2021)

暂无数据